Chemotherapy of Recurrent Esthesioneuroblastoma
- 1 April 1990
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 13 (2), 139-143
- https://doi.org/10.1097/00000421-199004000-00010
Abstract
Esthesioneuroblastoma is a rare epithelial tumor of the nasal olfactory mucosa. Its clinical course is characterized by indolent growth and persistent local recurrence and occasional distant metastases despite attempts at cure. Our report documents the response of a patient to a cisplatin-based drug combination and reviews the English-language literature of 25 patients treated with chemotherapy. We conclude that this tumor is sensitive to several different combinations and suggest guidelines for the use of chemotherapy in advanced or metastatic esthesioneuroblastoma.This publication has 20 references indexed in Scilit:
- Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicityCancer, 1981
- The diagnosis and surgical management of olfactory neuroblastoma: The role of craniofacial resectionThe Journal of Laryngology & Otology, 1981
- PHASE-II TRIAL OF CISPLATIN IN REFRACTORY CHILDHOOD-CANCER - CHILDRENS-CANCER-STUDY-GROUP REPORT1981
- Nasal neuroblastoma secreting vasopressin. A case reportCancer, 1980
- EsthesioneuroblastomaCancer, 1979
- Olfactory neuroblastoma (esthesioneuroblastoma). A light and ultrastructural study of two casesCancer, 1979
- EPIPODOPHYLLOTOXIN VM-26 IN TREATMENT OF CHILDHOOD NEUROBLASTOMA1977
- Cyclophosphamide treatment of patients with localized and regional neuroblastoma. A randomized studyCancer, 1976
- Olfactory neuroblastoma—A clinical analysis of 17 casesCancer, 1976
- The olfactory neuroepithelial tumorsA review of the literature and report of six additional casesCancer, 1957